Avalo Therapeutics, Inc. ($AVTX)
Sullivan Christopher Ryan โ Chief Financial Officer
Shares
13,834
Price
$18.55
Total Value
$256,655.28
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Sullivan Christopher Ryan |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | May 6, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | May 7, 2026 |
| Shares Sold | 13,834 |
| Price per Share | $18.55 |
| Total Value | $256,655.28 |
| Shares Owned After | 33,589 |
| Derivative | No |
| Accession Number | 0001810417-26-000010 |
| Document | View SEC Filing |